Design Therapeutics (DSGN) Amortization of Deferred Charges (2021 - 2024)
Design Therapeutics (DSGN) reported Amortization of Deferred Charges of -$3000.0 for Q4 2024, down 160.0% on a YoY basis from $5000.0 in Q1 2024, and down 400.0% sequentially from $1000.0 in Q3 2024.
Design Therapeutics (DSGN) Amortization of Deferred Charges (2021 - 2024) Analysis & Trends
Design Therapeutics (DSGN) has 4 years of Amortization of Deferred Charges data on file, last reported at -$3000.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortization of Deferred Charges fell 160.0% year-over-year to -$3000.0; the trailing twelve-month figure through Dec 2024 stood at $6000.0 (down 81.82% YoY), and the FY2024 full-year result was $6000.0, down 81.82% from the prior year.
- Amortization of Deferred Charges slipped to -$3000.0 in Q4 2024, from $1000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $21000.0 in Q2 2022 to a low of -$3000.0 in Q4 2024.
- A 4-year average of $8692.3 and a median of $10000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges fell 21.43% in 2022 and plunged 160.0% in 2024, its largest moves.
- Tracing DSGN's Amortization of Deferred Charges over 4 years: stood at $14000.0 in 2021, then fell by 21.43% to $11000.0 in 2022, then tumbled by 54.55% to $5000.0 in 2023, then sank by 160.0% to -$3000.0 in 2024.
- Business Quant data shows DSGN's Amortization of Deferred Charges at -$3000.0 in Q4 2024, $1000.0 in Q3 2024, and $4000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Design Therapeutics | 714.48 Mn | 491.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Sep 30, 2022 | 14,000.00 |